A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...
Texas is helping shape the future of psychedelic therapies. Here’s how they work and what access could look like.
The FDA is testing real-time clinical trial reporting in an effort to speed up the drug review and approval process.
After an executive order, the FDA announced it would prioritize the study of some psychedelic drugs for therapeutic use.
The Food and Drug Administration is a government agency that regulates certain food, drugs, cosmetics, and medical products.
A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...
The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other ...
WASHINGTON (AP) — Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions ...
BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly ...
The FDA moved approved marijuana products to schedule III to expand therapy access and state medical programs while ...